|
Market Closed -
Bombay S.E.
06:02:21 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 6.340 INR | +5.32% |
|
-1.55% | -22.11% |
Company Valuation: Vista Pharmaceuticals Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 160.9 | 403.6 | 339.2 | 311.9 | 705.8 | 825.3 |
| Change | - | 150.81% | -15.96% | -8.06% | 126.29% | 16.93% |
| Enterprise Value (EV) 1 | 313.4 | 552 | 464 | 409.5 | 784.5 | 892 |
| Change | - | 76.16% | -15.94% | -11.76% | 91.6% | 13.7% |
| P/E | -4.34x | -16.6x | -40.8x | -5.44x | -10.3x | -13.6x |
| PBR | 0.54x | 1.01x | 0.96x | 0.86x | 1.24x | 1.46x |
| PEG | - | 0.3x | 0.7x | -0x | 0.3x | 0.6x |
| Capitalization / Revenue | 0.71x | 31.9x | 86x | 31.1x | 6.86x | 8.19x |
| EV / Revenue | 1.38x | 43.6x | 118x | 40.8x | 7.63x | 8.85x |
| EV / EBITDA | -7.01x | -31.9x | -38.3x | -10.5x | -24.6x | -22.9x |
| EV / EBIT | -5.39x | -22.5x | -25.4x | -9.1x | -20.1x | -19.3x |
| EV / FCF | -10.4x | 69.9x | -46.9x | -16x | -27.2x | -14.6x |
| FCF Yield | -9.66% | 1.43% | -2.13% | -6.23% | -3.67% | -6.85% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.22 | -0.5441 | -0.2261 | -1.537 | -1.033 | -0.7906 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 227.6 | 12.66 | 3.945 | 10.04 | 102.9 | 100.7 |
| EBITDA 1 | -44.72 | -17.3 | -12.11 | -38.84 | -31.86 | -38.93 |
| EBIT 1 | -58.19 | -24.57 | -18.27 | -45.01 | -39.05 | -46.31 |
| Net income 1 | -36.77 | -18.85 | -8.319 | -56.62 | -45.12 | -46.49 |
| Net Debt 1 | 152.4 | 148.4 | 124.8 | 97.55 | 78.7 | 66.71 |
| Reference price 2 | 5.300 | 9.040 | 9.220 | 8.360 | 10.660 | 10.740 |
| Nbr of stocks (in thousands) | 30,365 | 44,651 | 36,794 | 37,309 | 66,211 | 76,842 |
| Announcement Date | 12/7/20 | 9/1/21 | 9/7/22 | 9/7/23 | 9/8/24 | 9/8/25 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 3.88M | |
| 35.3x | 6.64x | 22.99x | 0.89% | 48.07B | |
| 18.32x | 2.21x | 9.91x | 1.43% | 40.17B | |
| 28.51x | 4.06x | 16.82x | 0.57% | 12.42B | |
| 27.64x | 3.36x | 17.4x | 0.91% | 12.01B | |
| 19.17x | 3.41x | 11.88x | 3.76% | 9.38B | |
| 9.78x | 2.26x | 5.85x | 4.42% | 7.78B | |
| 29.92x | 3.92x | 18.22x | 0.16% | 7.27B | |
| 16x | 2.08x | 6.78x | 3.19% | 7.24B | |
| Average | 23.08x | 3.49x | 13.73x | 1.92% | 16.04B | |
| Weighted average by Cap. | 25.69x | 4.10x | 15.65x | 1.47% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- VISTAPH6 Stock
- Valuation Vista Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
